Respiratory syncytial virus had stymied vaccine research efforts for decades.Now there are two vaccines approved for the pathogen.The FDA on Wednesday approved Pfizer's RSV vaccine, which carries the brand name Abrysvo.The regulatory decision follows the approval of GSK's RSV shot, Arexvy, in early May.
[
add
]
[
|
|
...
]